We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bisphosphonate drug holidays.
- Authors
Nayak, S.; Greenspan, S.L.
- Abstract
The authors convey their response to a feedback about their report on the effect of bisphosphonate discontinuation on bone mineral density and fracture risk. Topics mentioned include position statement of the European Menopause and Andropause Society in 2017, discontinuation of treatment for one year after three years of prior risedronate treatment, and the null results for the impact of bisphosphonate discontinuation on risk of hip fracture or any clinical fracture.
- Subjects
BONE fracture prevention; DIPHOSPHONATES; OSTEOPOROSIS prevention; BONE fractures; OSTEOPOROSIS; RISK assessment; DECISION making in clinical medicine; TERMINATION of treatment; BONE density; RISEDRONATE; DISEASE risk factors
- Publication
Osteoporosis International, 2019, Vol 30, Issue 12, p2525
- ISSN
0937-941X
- Publication type
Article
- DOI
10.1007/s00198-019-05107-2